Ledger.Open graph →
SEC Form D · filed September 20, 2022

GeneCentric Therapeutics, Inc

Offering
$3.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
DURHAM, NC
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (17)

Clay Thorp · Durham, NCDirectorArnold Levine · Durham, NCDirectorCharles Perou · Durham, NCDirectorMichael Milburn · Durham, NCExec · DirectorMyla Lai-Goldman · Durham, NCDirectorEllen Lubman · Durham, NCDirectorMichael K. Perry · Brisbane, CADirectorChristopher K. Croddy · Brisbane, CADirectorSameer Jafri · Brisbane, CAExec · DirectorRyan K. Drant · Brisbane, CADirectorDarshana K. Zaveri · Brisbane, CADirectorLaurence J. Marton · Los Altos, CADirectorUna S. Ryan · Los Altos, CADirectorRobert S. Spiegel · Los Altos, CADirectorRamtin R. Agah · Los Altos, CADirectorShaun R. Bagai · Los Altos, CAExec · DirectorEllen Lubman · Durham, NCDirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗